FDA Permits Drug for Treatment of Inhalational Anthrax Cases

March 26, 2015 2:59 PM

17 0

The US Food and Drug Administration has given green signal to Anthrasil, a drug meant to treat patients infected by inhalational anthrax.

The FDA said the drug officially named as Anthrax Immune Globulin Intravenous (Human) will be used for treatment in combination with currently used antibacterial drugs. It is said that when patient starts exhibiting symptoms of the disease then it is considered to be too late.

Read more

To category page